M.Pharm with 15 to 20 years of experience in Formulation development of sterile, non-sterile Dosage forms as per guidelines of US, EU, Canada, Brazil and ROW market. Literature search, Pre - formulation and compatibility studies,formulation & development as per QbD, Scale-up and Technology transfer.
Master Degree or PG Diploma in Life Sciences or Biomedical Sciences or Pharmacy or Public Health or Clinical Research.
at least 4 years of demonstrated experience in clinical trial monitoring or clinical site management experience.
Doctoral Degree in Science from a recognised university or equivalent in stem cell biology, developmental biology, pharmacology, and or maternal or child health.
The candidate must have a M.S, M.Pharm, degree in Medicinal chemistry, Natural Products, Pharmaceutical Analysis from a PCI, AICTE, UGC, NAAC recognized, accredited University, Central Autonomous Institutes with 60% marks or above.
M.D Pharmacology M.V.Sc. Pharmacology M.Pharma, M.Sc. Medicinal Plants with specialization in Pharmacology from a recognized University Institution. Post Graduate degree in the Chemistry from a recognized University, Institution.
A Masters M.Pharm or M.Sc. or M.Tech. or M.E. or Bachelors B.Tech or B.E. or B.Pharm. An understanding of the Process Development and Industrial perspective of Biotherapeutics/ Biosimilars. Basic understanding of analytical techniques, statistical analysis, data management and analysis.
Master Degree in Pharmaceutical Sciences First-class with GPAT qualification Preferably in Pharmaceutics from a recognized University. developing nanoformulations, mammalian cell cultures, and in vivo experiments. Synthesis of Polymers, peptides Characterization of physicochemical Parameter, Determination of anticancer therapeutic effect in the in vitro assay systems, Validation of the in vitro results in the in vivo animal models of tumor-bearing mice model and infectious disease models